Respire Airway Clinics
Sleep Medicine

Obstructive vs Central Sleep Apnea: Which Type Do You Have and Why It Changes Your Treatment

A post-diagnosis comparison guide for patients with a sleep study report in hand.

Medical disclaimer: This page compares obstructive and central sleep apnea. It is for information, not a clinical evaluation. Treatment decisions depend on your specific sleep study and clinical picture. Last reviewed 2026-05-12 by Dr. Pradyut Waghray, MBBS, MD, FRCP (London), FCCP, FAMS.

Not all sleep apnea is the same. The treatment that helps obstructive sleep apnea can make central sleep apnea worse. The difference is the cause: obstructive sleep apnea (OSA) is a physical airway problem; central sleep apnea (CSA) is a brain-signal problem. The first is far more common. Both produce breathing pauses during sleep, but the device, the follow-up, and the underlying conditions you investigate alongside the apnea all differ.

A recurring picture in our Basheer Bagh clinic: the patient whose first CPAP titration did not resolve their AHI. A meaningful share of them have a central or complex pattern that the original setup did not catch. The device needs to match the type.

The core difference in one analogy

🔧

OSA: blocked pipe

The airway physically closes. The brain is sending the command to breathe; the chest is trying; but the soft palate, tongue base, or throat walls have collapsed inward. Air cannot get through.

Effort tracing moves. Airflow tracing flat.

🧠

CSA: failed pump

The airway is open. The brainstem briefly stops sending the order to breathe, so the chest does not move at all for those few seconds. The pipe is fine; the signal did not arrive.

Effort tracing flat. Airflow tracing flat.

Both types produce the same result on a pulse oximeter (an oxygen drop), which is why only a sleep study that records respiratory effort can tell them apart.

Obstructive sleep apnea: the more common type

OSA accounts for the large majority of sleep apnea cases. If you snore loudly, your partner has watched you stop breathing, and you wake up tired, you are almost certainly in this category.

The mechanism is mechanical. During sleep, especially in REM, the muscles holding the upper airway open relax. If the airway is anatomically narrow (small jaw, long soft palate, large tonsils, posteriorly positioned tongue) or extrinsically compressed (parapharyngeal fat, increased neck circumference), it collapses on the in-breath. The chest pulls. Nothing moves. Pressure builds. Eventually the brain fires an arousal, the throat muscles snap back, and a loud breath restarts the cycle.

Hallmark signs: loud witnessed snoring, gasping awakenings, morning headaches, daytime sleepiness, Epworth score that tends to run high. For the full symptom list, see sleep apnea symptoms and what causes OSA at the airway level.

Central sleep apnea: the rarer signal-failure type

Central sleep apnea is far less common, presents differently, and has different triggers. Loud witnessed snoring may be absent; the airway is fine. Patients often describe waking suddenly short of breath, awareness of pauses, fragmented or insomnia-like sleep, and daytime fatigue.

Common triggers for CSA

Heart failure: Often produces a Cheyne-Stokes pattern: breaths crescendo and decrescendo in cycles through the night.
Chronic opioid use: Suppresses brainstem respiratory drive and can produce both central events and irregular breathing patterns.
Stroke or brainstem disease: Structural changes to the respiratory control centres of the brain disrupt the signal.
High-altitude exposure: Low ambient oxygen destabilises the chemoreflex loop, producing central apnea even in otherwise healthy sleepers.
Treatment-emergent (after CPAP for OSA): The obstructive pattern resolves; central events that were masked become visible in the residual AHI download.
If you have CSA, the workup tends to widen: heart failure assessment, medication review (especially long-term opioids), and sometimes brain imaging all come into the picture.

Complex sleep apnea: when fixing the pipe reveals the pump

Some patients develop a central pattern only after CPAP is started for obstructive sleep apnea. This is treatment-emergent central sleep apnea, or complex sleep apnea syndrome.

The picture is straightforward. The obstructive events resolve on CPAP, as expected. But the residual AHI on the machine download shows a high count of central events that were not prominent on the original study. The pipe got fixed; the pump problem became visible.

In a substantial proportion of these patients, the central pattern resolves spontaneously over several weeks of consistent CPAP use as the chemoreflex stabilises. In those where it persists, adaptive servo-ventilation (ASV) is an option in selected cases.

Important ASV caveat

ASV is not recommended in patients with chronic systolic heart failure and a left ventricular ejection fraction of 45% or below, following the SERVE-HF trial finding of increased mortality in that population (NEJM 2015, AASM and AHA guidance updated accordingly). This is why a specialist review of the data, not just an automatic CPAP-to-ASV swap, is the right path.

How each type is diagnosed

A single in-lab sleep study (polysomnography) can distinguish OSA from CSA. The key signal is respiratory effort during each event.

Obstructive event

The chest and abdomen are still trying to breathe. Airflow is blocked at the upper airway. The effort tracing moves; the airflow tracing does not.

Central event

Neither the chest nor the abdomen moves. There is no effort. Airflow is zero because no breath was attempted.

Home sleep apnea tests are excellent for typical OSA in otherwise healthy adults. They are less reliable for distinguishing CSA from OSA, because most home devices do not record EEG or full effort channels with the same fidelity. If central sleep apnea is suspected, the in-lab study is the right test.

How each type is treated, and why CPAP is not the universal answer

For OSA

CPAP

First-line treatment for moderate to severe OSA. Most effective when used consistently every night.

Oral appliance

For mild to moderate OSA, or for patients who cannot tolerate CPAP. Advances the lower jaw to keep the airway open.

Weight management

A meaningful contributor in patients with obesity. Weight loss reduces parapharyngeal fat and neck circumference.

ENT surgery

When a clear anatomical target exists (deviated septum, large tonsils, redundant soft palate) and CPAP is not tolerated.

For CSA

Treat the underlying cause

Heart failure optimisation, opioid dose review, altitude management. Fixing the root problem often reduces CSA events substantially.

Adaptive servo-ventilation (ASV)

Used in selected CSA cases. Not recommended in chronic systolic heart failure with ejection fraction at or below 45% (SERVE-HF trial, NEJM 2015).

BiPAP-ST

Provides a backup respiratory rate for patients who need it. Used when the brainstem signal is consistently unreliable.

Supplemental oxygen

For specific high-altitude or hypoxic central patterns where chemoreflex instability is the driver.

For complex (treatment-emergent) CSA

Continue CPAP and re-evaluate at four to eight weeks; many patients self-resolve as the chemoreflex stabilises.
ASV reserved for persistent cases without the heart failure contraindication described above.

Which type is more dangerous?

Both types are serious. Severity, measured by AHI and oxygen desaturation, drives cardiovascular and cognitive risk more than the type label.

The cardiovascular risk literature applies to both: hypertension, atrial fibrillation, stroke, and heart failure all carry meaningful associations with untreated moderate to severe sleep apnea (American Heart Association scientific statement, Yeghiazarians et al., Circulation 2021). Central sleep apnea in the specific context of heart failure carries its own prognostic implications, often because it tracks with worse heart failure rather than independently driving the risk.

A crude ranking misses the point. Severity and underlying conditions drive risk. For the full picture, see the health risks of untreated sleep apnea.

Your specialists

Two consultants lead sleep medicine evaluations across Respire Airway Clinics in Hyderabad. Both consult at Basheer Bagh and at Jubilee Hills.

Dr. Pradyut Waghray

Dr. Pradyut Waghray

Founder & Senior Respiratory Physician

MBBS, MD, FRCP (London), FCCP, FAMS

Sleep MedicineRespiratory MedicineCOPD
  • 35+ years experience
  • International training (UK, USA)
  • Founder of Respire Clinics
Dr. Kunal Waghray

Dr. Kunal Waghray

Interventional Pulmonologist & Bronchoscopy Specialist

MD, DM, DNB, MNAMS, EDRM

Interventional BronchoscopyEBUSSleep Medicine
  • 1,000+ bronchoscopies performed
  • Advanced EBUS specialist
  • DM Pulmonology, Amrita Institute

Frequently asked questions

What is the difference between obstructive and central sleep apnea?

Obstructive sleep apnea is a blocked pipe: the upper airway physically closes during sleep while the chest tries to breathe. Central sleep apnea is a failed pump: the brainstem briefly stops sending the signal to breathe and the chest does not try at all. Both produce oxygen drops, but the cause, the treatment, and the workup differ.

Which type of sleep apnea is more dangerous?

Severity drives risk more than type. Untreated moderate to severe sleep apnea carries cardiovascular, metabolic, and accident risk regardless of whether it is obstructive or central. Central sleep apnea in the context of heart failure has its own prognostic implications, often reflecting the underlying heart condition.

Can you have both obstructive and central sleep apnea?

Yes. This is called complex sleep apnea syndrome, also known as treatment-emergent central sleep apnea. It often emerges after CPAP is started for obstructive sleep apnea, when the obstructive events resolve and central events become more visible. Many patients self-resolve over several weeks; the rest may benefit from adaptive servo-ventilation in selected cases.

How is central sleep apnea treated?

The first step is treating the underlying cause: optimising heart failure, reviewing chronic opioid use, or addressing altitude exposure. Adaptive servo-ventilation is used in selected cases, with the important caveat that it is not recommended for patients with chronic systolic heart failure and ejection fraction at or below 45%.

Is CPAP used for central sleep apnea?

Sometimes. CPAP works well for the obstructive component when both are present, and a proportion of central events resolve on CPAP over time. For persistent central apnea without a heart failure contraindication, adaptive servo-ventilation is more often the right device. The decision is case-by-case.

What causes central sleep apnea?

The most common causes are heart failure (often producing Cheyne-Stokes breathing), chronic opioid use, stroke, brainstem disease, and high-altitude exposure. A subset is treatment-emergent, appearing after CPAP is started for obstructive sleep apnea.

If your sleep study report is unclear, or your CPAP is not resolving your symptoms, a re-evaluation can clarify the type and match the device. At Respire, an interventional pulmonologist and a sleep physician review the full sleep study together, with an ENT in the same visit to assess the airway, at our Basheer Bagh or Jubilee Hills clinic. All consultations are confidential. No referral needed.

Reviewed by Dr. Pradyut Waghray, MBBS, MD, FRCP (London), FCCP, FAMS. 35+ years in pulmonology and sleep medicine.

Ready to Get Started?

Book an appointment with our integrated team today.